BRNS - Barinthus Biotherapeutics plc News

Barinthus Biotherapeutics Q2 EPS $(0.26) Beats $(0.30) Estimate

Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.26) per share which beat th

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) progressing towards closing Comple

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market sess

12 Health Care Stocks Moving In Monday's After-Market Session

Are KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

businesswire.com

Barinthus Biotherapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Bi

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,

Barinthus Biotherapeutics Q1 EPS $(0.14) Beats $(0.30) Estimate

Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.14) per share which beat th

Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments

GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“B

Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Ot

Are NSA, ULY, ESQ, BRNS Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

Barinthus Biotherapeutics Q4 EPS $(0.27) Beats $(0.40) Estimate

Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.27) per share which beat th

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

defenseworld.net

Short Interest in Barinthus Biotherapeutics PLC Sponsored ADR (NASDAQ:BRNS) Grows By 72.8%

Barinthus Biotherapeutics PLC Sponsored ADR (NASDAQ: BRNS - Get Free Report) saw a large increase in

zacks.com

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) might move higher on growing optimism about its e

defenseworld.net

Contrasting Barinthus Biotherapeutics (NASDAQ:BRNS) & Oncobiologics (NASDAQ:OTLK)

Oncobiologics (NASDAQ: OTLK - Get Free Report) and Barinthus Biotherapeutics (NASDAQ: BRNS - Get Fre

Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

12 Health Care Stocks Moving In Monday's Intraday Session

ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus The

SAN DIEGO , Oct. 24, 2025 /PRNewswire/ -- ChemDiv, a global provider of integrated drug discovery so

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Barinthus Biotherapeutics

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

12 Health Care Stocks Moving In Tuesday's After-Market Session

businesswire.com

BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & F

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

businesswire.com

BRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Barinthus Biotherapeutics

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune D

GERMANTOWN, MD and ALTRINCHAM, UK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- GERMANTOWN, MD and ALTRINCHAM,

accessnewswire.com

Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 20

OXFORD, GB AND GERMANTOWN, MD / ACCESS Newswire / June 9, 2025 / Barinthus Biotherapeutics plc annou

12 Health Care Stocks Moving In Friday's Pre-Market Session

Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments

OXFORD, United Kingdom and GERMANTOWN, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Barinthus Biotherapeu

accessnewswire.com

Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11

NEW YORK, NY / ACCESS Newswire / March 6, 2025 / Bill Enright, CEO and Gemma Brown, CFO of Barinthus

zacks.com

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) has been upgraded to a Zacks Rank #1 (Strong Buy)